Table 1.
Groups | None | Normal | Borderline | Abnormal | Extreme |
---|---|---|---|---|---|
(0 mm) | (1-4 mm) | (5-6 mm) | (7-10 mm ) | (12+ mm) | |
N (% Group) | N (% Group) | N (% Group) | N (% Group) | N (% Group) | |
22q11.2DS (N = 45) | 7 (15.6) | 20 (44.4) | 2 (4.4) | 5 (11.1) | 11(24.4) |
Male (N = 20) | 2 (4.4) | 10 (22.2) | 2 (4.4) | 1 (2.2) | 5 (11.1) |
Female (N =25) | 5 (11.1) | 10 (22.2) | 0 (0.0) | 4 (8.9) | 6 (13.3) |
| |||||
TD (N = 35) | 15 (42.9) | 13 (37.1) | 4 (11.4) | 3 (8.6) | 0 (0.0) |
Male (N = 22) | 9 (25.7) | 10 (28.6) | 1 (2.9) | 2 (5.6) | 0 (0.0) |
Female (N = 13) | 6 (17.1) | 3 (8.6) | 3 (8.6) | 1 (2.9) | 0 (0.0) |